Affordable Access

The American experience with desmopressin.

Authors
  • Bloom, D A
Type
Published Article
Journal
Clinical pediatrics
Publication Date
Jul 01, 1993
Volume
Spec No
Pages
28–31
Identifiers
PMID: 8039336
Source
Medline
License
Unknown

Abstract

Conclusive evidence of a polyuric etiology from a failure of vasopressin elevation led to a new pharmacologic approach to the treatment of childhood nocturnal enuresis. Desmopressin acetate, a vasopressin analogue, has been used successfully since 1978 to treat this condition. Desmopressin's efficacy at doses of 5 to 40 micrograms has been demonstrated in Europe and the United States. Similarly, its safety has been established, and it is a first-line choice for physicians worldwide.

Report this publication

Statistics

Seen <100 times